Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

New research sheds light on how ketamine affects the brain by targeting a specific NMDA receptor subtype, GluN1-2B-2D.

ETH researchers have developed a new gene switch that can be activated using a commercially available nitroglycerine patch ...

Prediction is very difficult, especially about the future”; whether it is the Nobel laureate Niels Bohr or others who have ...

You lean back from the dinner table, feeling like you physically couldn’t fit another bite in – but then someone offers pie ...